Pharma Watch: NeurogesX, Cowen Healthcare Enter Royalty Financing Pact
May 3, 2010 (FinancialWire) — NeurogesX, Inc. (NASDAQ: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, said that that it has entered into a $40 million royalty financing agreement with Cowen …